STIM:NASDAQ
Neuronetics Inc
$1.46
arrow_upward
+5.04%(+0.070) 1D
$1.43
arrow_downward
-2.05% (-0.030)bedtimeAfter hours
Closed: Jun 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$1.38
High
$1.49
Low
$1.38
Mkt. cap
101.60M
Avg. vol.
2.68M
Volume
0.00
52-wk high
$4.85
52-wk low
$0.80
EPS
-$0.55
Beta
1.05
Shares outstanding
69.59M
No. of employees
658
Open
$1.38
High
$1.49
Low
$1.38
Mkt. cap
101.60M
Avg. vol.
2.68M
Volume
0.00
52-wk high
$4.85
52-wk low
$0.80
EPS
-$0.55
Beta
1.05
Shares outstanding
69.59M
No. of employees
658
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to STIM in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for STIM in the last 3 months.
Highest
Current $1.46
$3.00 (+105.48%)
Average
$3.00 (+105.48%)
Lowest
$3.00 (+105.48%)
News stories
From sources across the web
Stock Titan
·
2 days ago
New Neuronetics sales chief gets 200,000-share stock grant
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com
AI content may include mistakes. Learn more